HPR and neoplasm: The in vitro anti-tumor efficacy of GD2-SIL-HPR was studied through cell proliferation experiments, which demonstrated that this formulation significantly inhibited NB cell proliferation compared to HPR, either free or encapsulated in untargeted liposomes.